Hyperbaric Oxygen Therapy in Sinonasal Disease: A Narrative Review of Mechanisms, Clinical Evidence, and Multidisciplinary Perspectives on Invasive Fungal Rhinosinusitis and Post-Radiotherapy Injury
Sinusitis · 2026
DOI: 10.3390/sinusitis10020021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sinusitis, 2026. Verfasst von Daniele Salvatore Paternò und 10 weiteren Autor:innen. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hyperbaric oxygen therapy (HBOT) is proposed as an adjunct in two sinonasal conditions of high morbidity: acute invasive fungal rhinosinusitis (AIFRS) and post-radiotherapy injury.
Methods
We conducted a narrative review and reported it against SANRA; PubMed/MEDLINE was searched (1980–2026; 1414 records screened, 589 retained), with Cochrane, society guidance and reference screening.
Results
No randomised trial has tested HBOT against sinonasal endpoints in either indication. In AIFRS the dedicated evidence is four uncontrolled series (n = 27, level 4); none reports how many candidates were unfit to pressurise, the largest synthesis did not identify HBOT as a survival predictor, and the only randomised experiment—murine—was negative. Mycology guidance supports it with marginal strength only (C; quality III), and hyperbaric indication lists omit it. For radiation injury, Cochrane 2023 reports low-certainty benefit in head-and-neck tissue, but HOPON found no reduction in osteoradionecrosis after dentoalveolar surgery (6.4% vs. 5.7%; OR 1.13, 95% CI 0.14–8.92), and pooled DAHANCA-21/NWHHT2009-1 data were non-significant (70% vs. 51% healing); all sinonasal use is extrapolated from the mandible. Middle-ear, not sinus, barotrauma is the commonest ENT complication.
Conclusions
HBOT is mechanistically coherent and may be considered case-by-case within a multidisciplinary team, but it is not a standard of care in either indication; the algorithm offered here is unvalidated.
Zitieren
APA
Paternò, D. S., Via, L. L., Maniaci, A., Lentini, M., Cordalonga, A., Testa, C. M., Piccitto, F., Provinzano, E., Tummino, P., Giudice, E. C. L., & Sorbello, M. (2026). Hyperbaric Oxygen Therapy in Sinonasal Disease: A Narrative Review of Mechanisms, Clinical Evidence, and Multidisciplinary Perspectives on Invasive Fungal Rhinosinusitis and Post-Radiotherapy Injury. Sinusitis. https://doi.org/10.3390/sinusitis10020021
Vancouver
Paternò DS, Via LL, Maniaci A, Lentini M, Cordalonga A, Testa CM, et al. Hyperbaric Oxygen Therapy in Sinonasal Disease: A Narrative Review of Mechanisms, Clinical Evidence, and Multidisciplinary Perspectives on Invasive Fungal Rhinosinusitis and Post-Radiotherapy Injury. Sinusitis. 2026. doi:10.3390/sinusitis10020021
BibTeX
@article{Patern2026,
author = {Paternò, Daniele Salvatore and Via, Luigi La and Maniaci, Antonino and Lentini, Mario and Cordalonga, Adriana and Testa, Caterina Maria and Piccitto, Francesco and Provinzano, Enrico and Tummino, Paolo and Giudice, Emilia Concetta Lo and Sorbello, Massimiliano},
title = {Hyperbaric Oxygen Therapy in Sinonasal Disease: A Narrative Review of Mechanisms, Clinical Evidence, and Multidisciplinary Perspectives on Invasive Fungal Rhinosinusitis and Post-Radiotherapy Injury},
journal = {Sinusitis},
year = {2026},
doi = {10.3390/sinusitis10020021}
}
EUVIMED